# Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

> **NCT06176716** · PHASE1 · UNKNOWN · sponsor: **Ahon Pharmaceutical Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** ET-26

## Key facts

- **NCT ID:** NCT06176716
- **Lead sponsor:** Ahon Pharmaceutical Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-06
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06176716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06176716, "Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06176716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*